Who has invested in Nura Bio?

The Column Group, Samsara BioCapital, Euclidean Capital are named among the investors backing Nura Bio.

Nura Bio Funding: $141M Raised, Series A (2024)

Nura Bio funding overview

Nura Bio is based in South San Francisco. Nura Bio has raised $141M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Nura Bio runs through 2024; nothing later has been disclosed. Investors on record include The Column Group, Samsara BioCapital, Euclidean Capital. 3 distinct backers are named across the disclosed rounds.

Nura Bio at a glance

Total raised: $141M
Latest round: Series A
Latest round date: September 2024
Headquarters: South San Francisco
Notable investors: The Column Group, Samsara BioCapital, Euclidean Capital

Frequently asked about Nura Bio funding

How much has Nura Bio raised?: Nura Bio has raised $141M in total disclosed funding across the rounds on record.
Who has invested in Nura Bio?: The Column Group, Samsara BioCapital, Euclidean Capital are named among the investors backing Nura Bio.
What was the latest Nura Bio funding round?: The most recent disclosed round is a Series A, announced in September 2024.
Where is Nura Bio based?: Nura Bio is based in South San Francisco.
When did Nura Bio last raise?: The last disclosed Nura Bio round closed in September 2024 at Series A.

Totals shown for Nura Bio aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.

Nura Bio Funding: $141M Raised, Series A (2024)

Nura Bio funding overview

Nura Bio at a glance

Frequently asked about Nura Bio funding

Companies related to Nura Bio (34)

Browse related funding lists (5)